|
|
|
Insider
Information: |
Katkin Keith |
Relationship: |
Director |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
1,258,490 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$4,827,703 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
1,258,490 |
|
|
Total
Value |
$4,827,703 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Avanir Pharmaceuticals |
AVNR |
President and CEO, Dir... |
2014-12-17 |
914,249 |
2006-05-25 |
0 |
Premium* |
|
Eledon Pharmaceuticals Ord Shs |
ELDN |
Director |
2017-05-10 |
12,119 |
|
0 |
Premium* |
|
Urovant Sciences Ltd. |
UROV |
PEO;CEO/Urovant Scienc... |
2020-02-19 |
199,680 |
2019-12-09 |
0 |
Premium* |
|
Syndax Pharmaceuticals Inc |
SNDX |
|
2024-02-07 |
65,000 |
2021-02-03 |
0 |
Premium* |
|
Rigel Pharmaceuticals Inc |
RIGL |
Director |
2021-05-19 |
25,000 |
2021-05-19 |
0 |
Premium* |
|
Emergent Biosolutions Inc. |
EBS |
Director |
2023-05-25 |
42,442 |
2022-04-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
76 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 4
|
76 Records found
|
|
Page 4 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|